Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG RIVM vs Russian Strains in NMIBC
NCT06767982Phase 4Completed
- Sponsor
- Ankara University
- Start
- Jan 2019
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in non-muscle-invasive bladder cancer (NMIBC), sponsored by Ankara University. Started Jan 2019; status: completed.
02
Drugs
bcg vaccine
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT06767982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06767982.